What a great week that was! FUN. In a word that's what the market has ceased to be lately. I can barely stand to watch it, much less invest in it. Yet rotation is the game and at some point even the most paralyzed of fools has to see a value or a reason to invest somewhere. But where.
Take Me Away Calgon! CCC Best chart in the NYSE.
Competitor Pall PLL is down quite a bit 45-35 yet Calgon continues to build and break out what's up? Add a nice Avonandale upgrade and PT of $19 to an already beautiful chart. This filtration play has found a new market in mercury. Hurray.
Sirf. Sure it could go to straight to $5 it could also be in the Google phone and go straight to $15. I am thinking this HAS to be one of the most tasty take outs in tech right now... lets be honest- selling channels got stuffed for xmas and inventory levels are high; GPS stocks have been smacked but they are still in everything and coming into phones in a big way... Sirf Technology' lost half of its value last Tuesday, following an ugly quarterly report . I'm looking at it. After all Broadcom, NXP and Atheros are all making acquisitions in the sector.
With Tuesday's selloff, Sirf, the No.1 independent GPS player, is more affordable than ever.
"It does put them in play more," says Craig Berger, an analyst at Friedman, Billings, Ramsey, who describes Sirf as the crown jewel of GPS chips.
Six weeks ago, Sirf had a roughly $1.5 billion market cap, making the firm a more expensive acquisition target than the slew of smaller, private GPS firms that exist, according to analysts.
With Tuesday's selloff though, Sirf's market value has now shrunk to $441 million. Whether that's cheap enough to draw a takeover bid remains to be seen.
SYNA (The Touch people) & CREE should form the base of any new portfolio.
We are due for a few things this week folks. One, a realization that maybe we are jumping the gun with the full out recession talk and two maybe we have overshot to the downside. Honestly I fear there is hyper inflation around the corner that will kill all of this but the proof of a recession is just not showing up. More likely a 0% growth Jan and then a rebound that is then fueled by this economic stimulus plan...And if the next jobs number is halfway decent, if the unemployment rate ticks down a tick... we rally hard.
The last economic report that tanked us so into the down 4% for the week murk was it ISM? I forget, but now of course I'm hearing chatter the dolts calibrated the numbers differently this time so look for a better number there and a readjust next time it rolls around. With a long stretch between fed meetings and the dollar strengthening, bonds selling off, things are shaping up good for a bottom having been put in place this past dreadful past week. It's not so much price action or volume (it wasn't there) but sentiment. Perhaps I'd call it a psychological bottom. Some sectors like retail went up on bad news which we like and as well these HUGE 20% down earnings when you ex out financials become up 10% so.... there is a big swath of value out there somewhere.
My street sources tell me there was some real buying going on when the market blipped up now and then not just short covering, some funds are taking shots at certain stocks, so should we.
The charts aere scary though so be careful, one that I came across in researching Calgon was Pall (also a rumored takeout candidate with Calgon) it's fallen into big support on a two year chart and for the amount of upside it offers, it also boasts greater downside protection than say taking a stab at ATI...
Now of course you heard about the Botox situation not a big deal, small subsector of Hollywood starlets can't breath- who cares? Of course it sent me into a fevorish competitor search and one tiny company I came across I hesitate to mention because of it's average trading volume of 105K and a market cap of $43 mil... but it is the onlyy FDA approved alternative to Botox and there is a ton of insider buying going way back including a large block at $6; the stock is now $2.70. Now with these news driven events you always wait to see if the breakout is real, can volume pick up several days north of 400K? But with the knowledge that it's a longshot, double or nothing , nothing being nothing sort of set up... I give you ARTE to do some DD on.
In the same sector sort of is Cryolife, a company I owned way back in the day, artificial skin graphs have now given way to human heart valves, I have to re-familiarize myself with the whole story and Cryolife's technology now, there used to be a lot of pigs involved which was a bit of a dna turnoff, they have probably moved past that... this is a name to research this week CRY.
10 Stock watch list : All Interesting Charts
EMKR
NYMX
WAVE
LXU
PTEC
BEBE
EFOI
GHDX
SIGM
PLL
4 Buys:
CCC
SIRF
SYNA
CREE
~ stoney
Take Me Away Calgon! CCC Best chart in the NYSE.
Competitor Pall PLL is down quite a bit 45-35 yet Calgon continues to build and break out what's up? Add a nice Avonandale upgrade and PT of $19 to an already beautiful chart. This filtration play has found a new market in mercury. Hurray.
Sirf. Sure it could go to straight to $5 it could also be in the Google phone and go straight to $15. I am thinking this HAS to be one of the most tasty take outs in tech right now... lets be honest- selling channels got stuffed for xmas and inventory levels are high; GPS stocks have been smacked but they are still in everything and coming into phones in a big way... Sirf Technology' lost half of its value last Tuesday, following an ugly quarterly report . I'm looking at it. After all Broadcom, NXP and Atheros are all making acquisitions in the sector.
With Tuesday's selloff, Sirf, the No.1 independent GPS player, is more affordable than ever.
"It does put them in play more," says Craig Berger, an analyst at Friedman, Billings, Ramsey, who describes Sirf as the crown jewel of GPS chips.
Six weeks ago, Sirf had a roughly $1.5 billion market cap, making the firm a more expensive acquisition target than the slew of smaller, private GPS firms that exist, according to analysts.
With Tuesday's selloff though, Sirf's market value has now shrunk to $441 million. Whether that's cheap enough to draw a takeover bid remains to be seen.
SYNA (The Touch people) & CREE should form the base of any new portfolio.
We are due for a few things this week folks. One, a realization that maybe we are jumping the gun with the full out recession talk and two maybe we have overshot to the downside. Honestly I fear there is hyper inflation around the corner that will kill all of this but the proof of a recession is just not showing up. More likely a 0% growth Jan and then a rebound that is then fueled by this economic stimulus plan...And if the next jobs number is halfway decent, if the unemployment rate ticks down a tick... we rally hard.
The last economic report that tanked us so into the down 4% for the week murk was it ISM? I forget, but now of course I'm hearing chatter the dolts calibrated the numbers differently this time so look for a better number there and a readjust next time it rolls around. With a long stretch between fed meetings and the dollar strengthening, bonds selling off, things are shaping up good for a bottom having been put in place this past dreadful past week. It's not so much price action or volume (it wasn't there) but sentiment. Perhaps I'd call it a psychological bottom. Some sectors like retail went up on bad news which we like and as well these HUGE 20% down earnings when you ex out financials become up 10% so.... there is a big swath of value out there somewhere.
My street sources tell me there was some real buying going on when the market blipped up now and then not just short covering, some funds are taking shots at certain stocks, so should we.
The charts aere scary though so be careful, one that I came across in researching Calgon was Pall (also a rumored takeout candidate with Calgon) it's fallen into big support on a two year chart and for the amount of upside it offers, it also boasts greater downside protection than say taking a stab at ATI...
Now of course you heard about the Botox situation not a big deal, small subsector of Hollywood starlets can't breath- who cares? Of course it sent me into a fevorish competitor search and one tiny company I came across I hesitate to mention because of it's average trading volume of 105K and a market cap of $43 mil... but it is the onlyy FDA approved alternative to Botox and there is a ton of insider buying going way back including a large block at $6; the stock is now $2.70. Now with these news driven events you always wait to see if the breakout is real, can volume pick up several days north of 400K? But with the knowledge that it's a longshot, double or nothing , nothing being nothing sort of set up... I give you ARTE to do some DD on.
In the same sector sort of is Cryolife, a company I owned way back in the day, artificial skin graphs have now given way to human heart valves, I have to re-familiarize myself with the whole story and Cryolife's technology now, there used to be a lot of pigs involved which was a bit of a dna turnoff, they have probably moved past that... this is a name to research this week CRY.
10 Stock watch list : All Interesting Charts
EMKR
NYMX
WAVE
LXU
PTEC
BEBE
EFOI
GHDX
SIGM
PLL
4 Buys:
CCC
SIRF
SYNA
CREE
~ stoney